Bixiye
P34-24 Updated Reimbursement Policies, Effective July 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1591 - 1600 ee natiijooyinka 3289
Bixiye
QP35-24 Inconsistent Claim Denials for Self-Administered Drugs, Medicare Advantage and Platinum Blue
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 24, 2024
Bixiye
QP36-24 Updated Request Form for Medical Policy Coverage Exception Requests
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 24, 2024
Bixiye
QP16R1-24 Authorization Submissions for Medical Drugs for Non-Oncologic Use
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP34-24 Mileage Reimbursement for Transportation Providers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP32-24 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP30-24 Update for New to Market Medical Drugs: prademagene zamikeracel and marnetegragene autotemcel
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP33-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP31-24 Rare Disease Benefit Mandate
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
2024 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2024